Immunome Inc (IMNM)
15.46
-0.28
(-1.81%)
USD |
NASDAQ |
May 06, 16:00
15.46
0.00 (0.00%)
After-Hours: 20:00
Immunome Shareholders Equity (Quarterly): 119.88M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 119.88M |
| September 30, 2023 | 6.076M |
| June 30, 2023 | 9.338M |
| March 31, 2023 | 13.86M |
| December 31, 2022 | 16.65M |
| September 30, 2022 | 23.08M |
| June 30, 2022 | 30.28M |
| March 31, 2022 | 37.87M |
| Date | Value |
|---|---|
| December 31, 2021 | 48.18M |
| September 30, 2021 | 54.79M |
| June 30, 2021 | 60.62M |
| March 31, 2021 | 37.88M |
| December 31, 2020 | 41.34M |
| September 30, 2020 | -49.08M |
| June 30, 2020 | 9.084M |
| December 31, 2019 | -35.63M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-49.08M
Minimum
Sep 2020
119.88M
Maximum
Dec 2023
26.51M
Average
26.68M
Median
Shareholders Equity (Quarterly) Benchmarks
| Ayala Pharmaceuticals Inc | -24.42M |
| Tenax Therapeutics Inc | 8.098M |
| GE HealthCare Technologies Inc | 7.408B |
| Exelixis Inc | 2.128B |
| Puma Biotechnology Inc | 53.44M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 148.54M |
| Total Liabilities (Quarterly) | 28.66M |
| Current Ratio | 6.629 |